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Key findings
Data from the 2011 Survey 
of Pathways to Diagnosis 
and Services
• The median age when school 
-aged children with special 
health care needs (CSHCN) 
and autism spectrum disorder 
(ASD) were first identified as 
having ASD was 5 years.
• School-aged CSHCN 
identified as having ASD at a 
younger age (under age 5 years) 
were identified most often by 
generalists and psychologists, 
while those identified later 
(aged 5 years and over)
were identified primarily by 
psychologists and psychiatrists.
• Nine out of 10 school-aged 
CSHCN with ASD use one 
or more services to meet their 
developmental needs. Social 
skills training and speech or 
language therapy are the most 
common, each used by almost 
three-fifths of these children.
• More than one-half of 
school-aged CSHCN with ASD 
use psychotropic medication.
Autism Spectrum Disorder (ASD) is a set of complex neurodevelopment 
disorders characterized by mild to severe problems in social interaction 
and communication along with restricted repetitive behavior patterns (1).
ASD symptoms begin before age 3 years and last into adulthood, although 
symptoms may improve over time. There is no one best treatment for ASD, 
but the American Academy of Pediatrics recommends early behavioral 
intervention once a child is diagnosed (2). Nearly all children (94%) with ASD 
have special health care needs, defined as requiring health or related services 
beyond those required by children generally (3,4). This report provides 
information on diagnosis and treatment of school-aged (6-17 years) children 
with special health care needs (CSHCN) and ASD.
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One-half of school-aged CSHCN with ASD were aged 5 years 
and over when they were first identified as having ASD.
Figure 1. Percent d is tribu tion  o f ch ild 's  age w hen parent o r guard ian w as firs t told tha t child had 
au tism  spectrum  d iso rder am ong ch ildren aged 6 -1 7  years w ith  specia l health care needs and 
au tism  spectrum  disorder: United States, 2011
A ge 6 years 
and ove r 
39.9%
NOTE: A ccess data tab le  fo r F igure 1 at: http ://ww w.cdc.goV /nchs/data/databriefs/db97_tables.pdf#1. 
SOURCE: CDC/NCHS, Survey o f Pathways to  D iagnosis and Services, 2011.
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• Fewer than one-fifth of school-aged CSHCN with ASD were identified as having ASD within 
the first 2 years of life.
• Two-fifths of school-aged CSHCN with ASD were aged 6 years and over when first identified 
as having ASD.
CSHCN are identified as having ASD by a range of health care providers.
• School-aged CSHCN identified as having ASD before age 5 years were most often 
identified by generalists (such as pediatricians, family physicians, and nurse practitioners) and 
psychologists.
• Relative to those school-aged CSHCN identified at age 5 years and over, those identified 
as having ASD before age 5 years were more likely to be identified by generalists, specialist 
pediatricians, neurologists, and multidisciplinary teams.
• School-aged CSHCN identified as having ASD at age 5 years and over were identified 
primarily by psychologists and psychiatrists.
Figure 2. P ercent d is tribution o f type  o f docto r o r health care p rov ider w ho  firs t told parent o r guard ian tha t child had 
au tism  spectrum  disorder, by ch ild 's  age w hen parent o r guard ian w as firs t told, am ong child ren aged 6 -1 7  years w ith 









'Ind ica tes a statistica lly significant d iffe rence (p  < .05) between age groups.
NOTES: A ccess data tab le  fo r F igure 2 at: http://ww w.cdc.goV /nchs/data/databriefs/db97_tables.pdf#2. CSHCN is children w ith specia l health care needs. 
A SD  is autism spectrum  disorder.
SOURCE: CDC/NCHS, Survey o f Pathways to  D iagnosis and Services, 2011.
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Just over one-half of school-aged CSHCN with ASD use three or more 
health care services to meet their developmental needs.
• Across both age groups, approximately 9 out of 10 CSHCN with ASD use one or more of the 
eight services included in the Pathways survey.
• Younger CSHCN with ASD are more likely than older CSHCN with ASD to use any of these 
eight services and to use three or more of these services.
• The most commonly used services are social skills training and speech or language therapy for 
both age groups.
• About 40% of school-aged CSHCN with ASD use behavioral intervention or modification 
services to meet developmental needs.
• Younger CSHCN with ASD are more likely than older CSHCN with ASD to use occupational 
therapy and speech or language therapy to meet their developmental needs.
Figure 3. P ercentage o f child ren aged 6 -1 7  years w ith  specia l health care needs and au tism  spectrum  d iso rder w ho 
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'Ind ica tes a statistica lly significant d iffe rence (p < .05) between age groups.
NOTE: A ccess data tab le  fo r F igure 3 at: http ://ww w.cdc.goV /nchs/data/databriefs/db97_tables.pdf#3. 
SOURCE: CDC/NCHS, Survey o f Pathways to  D iagnosis and Services, 2011.
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More than one-half of school-aged CSHCN with ASD use one or more 
psychotropic medications to meet their developmental needs.
• More than one-half of school-aged CSHCN with ASD use at least one psychotropic medication 
to meet their developmental needs.
• Almost one-third of school-aged CSHCN with ASD use stimulant medications, one-quarter use 
anti-anxiety or mood-stabilizing medications, and one-fifth use antidepressants.
Figure 4. P ercentage o f child ren aged 6 -1 7  years w ith  specia l health care needs and au tism  spectrum  d iso rder w ho 
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NOTE: A ccess data tab le  fo r F igure 4  at: http ://ww w.cdc.goV /nchs/data/databriefs/db97_tables.pdf#4. 
SOURCE: CDC/NCHS, Survey o f Pathways to  D iagnosis and Services, 2011.
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Summary
This report describes school-aged CSHCN with ASD, looking at when they were reported to be 
first identified as having ASD, who made the identification, and the services and medications 
they currently receive to meet their developmental needs. Early identification is an important 
first step toward making sure that children with ASD and their families are able to access and 
benefit from early intervention, which has been associated with positive developmental outcomes 
(5-7). Among school-aged CSHCN with ASD, a majority were aged 5 years and over when they 
were first identified as having ASD, while only one in five was identified as having ASD within 
the first 3 years of life. A wide range of health care providers—including general and specialist 
physicians, mental health specialists, and others—were the first professionals to identify CSHCN 
as having ASD. A majority of CSHCN recognized as having ASD at age 5 years and over 
were identified by psychologists and psychiatrists, whereas no one type of health care provider 
identified more than 20% of CSHCN recognized as having ASD before age 5 years.
Most families use a combination of services to address the developmental needs of their CSHCN 
with ASD. Social skills training and speech or language therapy are the most commonly used, 
followed by occupational therapy. Twelve percent of CSHCN with ASD do not use any of the 
eight services included in the survey, whereas fewer than one-half use behavioral intervention 
or modification services, the most well-established and efficacious intervention for ASD (2,8,9). 
Younger CSHCN with ASD are more likely than older CSHCN with ASD to use any services and 
multiple services, in part because they are more likely to use occupational therapy and speech or 
language therapy to meet their developmental needs. More than one-half of school-aged CSHCN 
with ASD use at least one psychotropic medication, with stimulants being the most common. 
Medication use spans a variety of medication classes, perhaps reflecting treatment of co-occurring 
symptoms or absence of clear practice guidelines for psychotropic medication use in children 
with ASD (10).
Definitions
Children with special health care needs (CSHCN): The National Survey of CSHCN (NS-CSHCN) 
used the CSHCN Screener (11) to identify CSHCN. This screener uses the health consequences 
that children experience as criteria for identifying special health care needs, rather than just 
specific diagnoses or health conditions.
Autism Spectrum Disorder (ASD): CSHCN were first identified as ever having or currently 
having ASD based on two questions on the NS-CSHCN: 1) “Has a doctor or other health care 
provider ever told you that [the child] had autism, Asperger’s disorder, pervasive developmental 
disorder, or other autism spectrum disorder?” and 2) “Does [the child] currently have autism or 
an autism spectrum disorder?” When recontacted to participate in the Pathways survey, parents 
or guardians were asked to confirm if their child ever had autism or ASD. If yes, they were then 
asked, “To the best of your knowledge, does [the selected child] currently have autism or an 
autism spectrum disorder.” This analysis is based on those CSHCN who were identified in the 
Pathways survey as currently having ASD.
Health care professional: Respondents were asked, “What type of doctor or other health care 
provider first told you that [the selected child] had autism or autism spectrum disorder?”
Physician types were categorized as follows: 1) Pediatricians, family practice doctors, or other
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providers in general practice, which includes pediatric or family practice nurse practitioners, 
or physician’s assistants; 2) developmental pediatricians or other specialist pediatricians; 3) 
psychologists, including school psychologists or councilors; 4) psychiatrists (medical doctors); 5) 
neurologists; 6) a team of professionals or multidisciplinary team; and 7) specialist doctors (other 
than developmental pediatricians, psychiatrists, or neurologists) and other health care providers 
(i.e., school nurses; physical, occupational, speech, or other therapists; etc.).
Health care services: The Pathways survey asked about the following eight health care services: 
behavioral intervention or modification services; sensory integration therapy; cognitive based 
therapy; school-based occupational therapy or other occupational therapy; school-based physical 
therapy or other physical therapy; school-based social skills training or other social skills training; 
school-based speech or language therapy or other speech or language therapy; and alternative 
health care or treatment. For each selected service, parents or guardians were asked whether or 
not their child ever used the service to meet [his/her] developmental needs, and if so, whether the 
child currently uses the service on a regular basis.
Medication use: To determine what medication the child currently uses, the parent or guardian 
was asked to report “whether or not the child ever used this type of medication to meet [his/her] 
developmental needs,” and if so, whether the child currently uses the medication. Each type of 
medication was asked about separately. Specific medication names were not solicited, but if the 
parent knew the name of the drug but not the type, the interviewer could refer to a list of drug 
names matched to type of medication.
Data sources and methods
The Survey of Pathways to Diagnosis and Services is a nationally representative survey about 
children with special health care needs (CSHCN) aged 6-17 years ever diagnosed with autism 
spectrum disorder (ASD), intellectual disability, or developmental delay. The survey and this 
report are part of the Pathways to Diagnosis and Services Study, which was sponsored and co-led 
by the National Institute of Mental Health, using funds available from the American Recovery 
and Reinvestment Act of 2009.
Parents or guardians who previously participated in the 2009-2010 NS-CSHCN (sponsored by 
the Maternal and Child Health Bureau) and who reported that their child had ever been diagnosed 
with at least one of the three selected developmental conditions were recontacted via landline 
or cell telephone to participate in the Pathways survey. To be eligible, the CSHCN had to be 
aged 6-17 years at the time of the Pathways interview and still living in the same household 
as the recontacted parent or guardian. Of the parents or guardians with eligible CSHCN, 71% 
were successfully recontacted and 87% agreed to participate. A total of 4,032 interviews were 
completed from February-May 2011, an average of 9 months after the initial interview. This 
report presents selected measures of diagnostic history and health care experience for the 
1,420 CSHCN who were reported to have an ASD at the time of the Pathways interview. (See 
“Definitions” for question wording.) All estimates shown in this report are weighted to produce 
national estimates representative of the noninstitutionalized population of U.S. CSHCN with ASD 
as estimated from the 2009-2010 NS-CSHCN. The NS-CSHCN response and realization rates 
were about 25%; unpublished analyses suggest no significant nonresponse bias in estimates of 
the prevalence or characteristics of CSHCN with ASD. For more information about the Pathways 
survey, including questionnaire content, please visit: http://www.cdc.gov/nchs/slaits/spds.htm.
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